CLINICAL TRIAL

Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Phase II Open-Label Trial

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: ClinicalTrials.gov
Date: 2026-06-22
Source: ClinicalTrials.gov
DOI: Unavailable
PubMed: Unavailable

Authors

University Health Network Toronto

Watch author

Derived topics and classifications

psilocybin End-of-Life Distress Clinical Trial Safety Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Selective outcome reporting and non-reporting in trials of psychedelic drugs for mental disordersEuropean Psychiatry · 2025-04-01 Oregon's Psilocybin Services: A Summary and Public Health Commentary.Health behavior research · 2026-01-01 Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome.Psychopharmacology · 2023-01-01 The effect of psilocybin upon the systemic, pulmonary, and coronary circulation of the intact dog.Archives internationales de pharmacodynamie et de therapie · 1962-05-01